Results per Page:
Boost and attack approach for metastatic prostate cancer therapy!
From the Lee Lab, Human Biology and Clinical Research Divisions, Cancer Consortium
Improving immunotherapy for advanced prostate cancer
Preclinical work identifies better target and recruits more immune cells to make CAR T-cell therapy work for solid tumors
Award will fund research into new metastatic prostate cancer therapies
Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
Building better lab models of human tumors
Dr. John Lee receives $1.5M NIH New Innovator Award for creative young scientists with high-risk, high-reward projects
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
Summaries of recent Fred Hutch research findings and other news, plus resources for the American Society of Hematology’s annual meeting
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Experts discuss navigating cancer and cancer research during the pandemic
Hutch panelists offer their insights on how COVID-19 has impacted patients as well as their efforts to develop cancer treatments
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment